Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REPL

Replimune Group Inc

Jun 12 • 01:07PM ET

8.90

+0.28 3.22 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CCCC CHRS ZNTL ALLO ALEC CLLS ELDN IMRX LENZ GLSI

| Held by: XBI IWM IWN VTI IBB SCHA VXF IWC DFAS PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.58	Insider Own	7.67%	Shs Outstand	79.63M	Perf Week	-6.04%
Market Cap	734.71M	Forward P/E	-	EPS next Y	-1.81	Insider Trans	-1.74%	Shs Float	76.24M	Perf Month	67.88%
Enterprise Value	541.92M	PEG	-	EPS next Q	-0.71	Inst Own	102.42%	Short Float	34.04%	Perf Quarter	24.62%
Income	-314.85M	P/S	-	EPS this Y	-5.96%	Inst Trans	-6.04%	Short Ratio	3.53	Perf Half Y	-9.39%
Sales	0.00M	P/B	3.37	EPS next Y	44.44%	ROA	-67.19%	Short Interest	25.95M	Perf YTD	-8.46%
Book/sh	2.64	P/C	2.73	EPS next 5Y	27.37%	ROE	-90.88%	52W High	13.24 -32.80%	Perf Year	-9.99%
Cash/sh	3.26	P/FCF	-	EPS past 3/5Y	-10.73% -14.85%	ROIC	-111.33%	52W Low	1.50 493.18%	Perf 3Y	-62.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.90% 12.61%	Perf 5Y	-73.83%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-13.96%	Oper. Margin	-	ATR (14)	0.90	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	64.84	Recom	3.25
Dividend Gr. 3/5Y	- -	Current Ratio	5.60	EPS Q/Q	3.16%	SMA20	23.34%	Beta	0.91	Target Price	4.67
Payout	-	Debt/Eq	0.36	Sales Q/Q	-	SMA50	74.57%	Rel Volume	0.29	Prev Close	8.62
Employees	479	LT Debt/Eq	0.34	Earnings	Feb 03 BMO	SMA200	27.57%	Avg Volume	7.35M	Price	8.90
IPO	Jul 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.89% 0.00%	Trades		Volume	1,234,300	Change	3.22%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)